{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:19:35Z","timestamp":1789507175432,"version":"build-2803163510"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41579-026-01289-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:15:13Z","timestamp":1771938913000},"page":"425-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Varicella zoster virus and the central nervous system"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-2063","authenticated-orcid":false,"given":"Benson","family":"Ogunjimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Warren-Gash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8393-296X","authenticated-orcid":false,"given":"Werner J. D.","family":"Ouwendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-0534","authenticated-orcid":false,"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-9704","authenticated-orcid":false,"given":"Trine H.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Koelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"1289_CR1","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1017\/S0950268811002640","volume":"140","author":"J Bilcke","year":"2012","unstructured":"Bilcke, J. et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol. Infect. 140, 2096\u20132109 (2012).","journal-title":"Epidemiol. Infect."},{"key":"1289_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","volume":"101","author":"S Blumental","year":"2015","unstructured":"Blumental, S., Sabbe, M. & Lepage, P. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch. Dis. Child. 101, 16\u201322 (2015).","journal-title":"Arch. Dis. Child."},{"key":"1289_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/00006454-200210000-00009","volume":"21","author":"K Galil","year":"2002","unstructured":"Galil, K., Brown, C., Lin, F. & Seward, J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J. 21, 931\u2013934 (2002).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1289_CR4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3741","volume":"137","author":"M Marin","year":"2016","unstructured":"Marin, M., Marti, M., Kambhampati, A., Jeram, S. M. & Seward, J. F. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics 137, e20153741 (2016).","journal-title":"Pediatrics"},{"key":"1289_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/cid\/ciu918","volume":"60","author":"VA Morrison","year":"2015","unstructured":"Morrison, V. A. et al. Long-term persistence of zoster vaccine efficacy. Clin. Infect. Dis. 60, 900\u2013909 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/cid\/ciab629","volume":"74","author":"C Boutry","year":"2021","unstructured":"Boutry, C. et al. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70. Clin. Infect. Dis. 74, 1459\u20131467 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L. et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N. Engl. J. Med. 375, 1019\u20131032 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR8","doi-asserted-by":"publisher","unstructured":"Winzig, F. et al. Genetic landscape of a cohort of children with varicella-zoster virus encephalitis, cerebellitis and stroke. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaf448 (2025). This report describes the results of whole exome sequencing in cohorts of children with VZV encephalitis, cerebellitis and stroke, which provide information on potentially pathogenic genetic variants that regulate cellular responses linked to interferon responses, autophagy, cell death and inflammation that might precipitate severe CNS infection in individuals with deleterious defects.","DOI":"10.1093\/infdis\/jiaf448"},{"key":"1289_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.vaccine.2009.01.019","volume":"27","author":"NAT van der Maas","year":"2009","unstructured":"van der Maas, N. A. T., Bondt, P. E. V., Melker, H. de & Kemmeren, J. M. Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection. Vaccine 27, 1970\u20131973 (2009).","journal-title":"Vaccine"},{"key":"1289_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cid\/cit659","volume":"58","author":"SL Thomas","year":"2013","unstructured":"Thomas, S. L., Minassian, C., Ganesan, V., Langan, S. M. & Smeeth, L. Chickenpox and risk of stroke: a self-controlled case series analysis. Clin. Infect. Dis. 58, 61\u201368 (2013). This work presents convincing data on how chickenpox can lead to stroke.","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer, J., Pacou, M., Gauthier, A. & Brown, M. M. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 82, 206\u2013212 (2014).","journal-title":"Neurology"},{"key":"1289_CR12","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41591-025-03972-5","volume":"31","author":"V Polisky","year":"2025","unstructured":"Polisky, V. et al. Varicella-zoster virus reactivation and the risk of dementia. Nat. Med. 31, 4172\u20134179 (2025).","journal-title":"Nat. Med."},{"key":"1289_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","volume":"641","author":"M Eyting","year":"2025","unstructured":"Eyting, M. et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 641, 438\u2013446 (2025).","journal-title":"Nature"},{"key":"1289_CR14","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1093\/cid\/ciaf440","volume":"81","author":"E Rayens","year":"2025","unstructured":"Rayens, E. et al. Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged \u226550 years. Clin. Infect. Dis. 81, e441\u2013e445 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR15","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","volume":"30","author":"M Taquet","year":"2024","unstructured":"Taquet, M., Dercon, Q., Todd, J. A. & Harrison, P. J. The recombinant shingles vaccine is associated with lower risk of dementia. Nat. Med. 30, 2777\u20132781 (2024).","journal-title":"Nat. Med."},{"key":"1289_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03569-2","volume":"9","author":"DP Depledge","year":"2018","unstructured":"Depledge, D. P. et al. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61. Nat. Commun. 9, 1167 (2018). This study describes the discovery of the VZV latency-associated transcript VLT, which is now considered the hallmark of VZV latency.","journal-title":"Nat. Commun."},{"key":"1289_CR17","doi-asserted-by":"publisher","first-page":"e01568","DOI":"10.1128\/mBio.01568-20","volume":"11","author":"SE Braspenning","year":"2020","unstructured":"Braspenning, S. E. et al. Decoding the architecture of the varicella-zoster virus transcriptome. mBio 11, e01568\u201320 (2020).","journal-title":"mBio"},{"key":"1289_CR18","doi-asserted-by":"publisher","first-page":"e01710","DOI":"10.1128\/JVI.01710-17","volume":"91","author":"A Markus","year":"2017","unstructured":"Markus, A. et al. Varicella-zoster virus expresses multiple small noncoding RNAs. J. Virol. 91, e01710\u2013e01717 (2017).","journal-title":"J. Virol."},{"key":"1289_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49112-4","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Identification and characterization of varicella zoster virus circular RNA in lytic infection. Nat. Commun. 15, 4932 (2024).","journal-title":"Nat. Commun."},{"key":"1289_CR20","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1128\/JVI.02137-08","volume":"83","author":"M Reichelt","year":"2009","unstructured":"Reichelt, M., Brady, J. & Arvin, A. M. The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J. Virol. 83, 3904\u20133918 (2009).","journal-title":"J. Virol."},{"key":"1289_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fmicb.2020.01179","volume":"11","author":"WJD Ouwendijk","year":"2020","unstructured":"Ouwendijk, W. J. D. et al. Analysis of virus and host proteomes during productive HSV-1 and VZV infection in human epithelial cells. Front. Microbiol. 11, 1179 (2020).","journal-title":"Front. Microbiol."},{"key":"1289_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/v10070349","volume":"10","author":"DP Depledge","year":"2018","unstructured":"Depledge, D. P., Sadaoka, T. & Ouwendijk, W. J. D. Molecular aspects of varicella-zoster virus latency. Viruses 10, 349 (2018).","journal-title":"Viruses"},{"key":"1289_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4451","volume":"235","author":"WJ Ouwendijk","year":"2015","unstructured":"Ouwendijk, W. J. & Verjans, G. M. Pathogenesis of varicelloviruses in primates. J. Pathol. 235, 298\u2013311 (2015).","journal-title":"J. Pathol."},{"key":"1289_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni, L., Sen, N., Oliver, S. L. & Arvin, A. M. Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol. 12, 197\u2013210 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"1289_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/v11060502","volume":"11","author":"R Mahalingam","year":"2019","unstructured":"Mahalingam, R. et al. Current in vivo models of varicella-zoster virus neurotropism. Viruses 11, 502 (2019).","journal-title":"Viruses"},{"key":"1289_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1542\/peds.68.5.735","volume":"68","author":"C Grose","year":"1981","unstructured":"Grose, C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 68, 735\u2013377 (1981).","journal-title":"Pediatrics"},{"key":"1289_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM198002213020807","volume":"302","author":"JM Leclair","year":"1980","unstructured":"Leclair, J. M., Zaia, J. A., Levin, M. J., Congdon, R. G. & Goldmann, D. A. Airborne transmission of chickenpox in a hospital. N. Engl. J. Med. 302, 450\u2013453 (1980).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/infdis\/163.5.1016","volume":"163","author":"CM Koropchak","year":"1991","unstructured":"Koropchak, C. M. et al. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis. 163, 1016\u20131022 (1991).","journal-title":"J. Infect. Dis."},{"key":"1289_CR29","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/infdis\/161.6.1095","volume":"161","author":"Y Asano","year":"1990","unstructured":"Asano, Y. et al. Severity of viremia and clinical findings in children with varicella. J. Infect. Dis. 161, 1095\u20131098 (1990).","journal-title":"J. Infect. Dis."},{"key":"1289_CR30","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1128\/jvi.69.9.5236-5242.1995","volume":"69","author":"JF Moffat","year":"1995","unstructured":"Moffat, J. F., Stein, M. D., Kaneshima, H. & Arvin, A. M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69, 5236\u20135242 (1995).","journal-title":"J. Virol."},{"key":"1289_CR31","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20040634","volume":"200","author":"C-C Ku","year":"2004","unstructured":"Ku, C.-C. et al. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J. Exp. Med. 200, 917\u2013925 (2004).","journal-title":"J. Exp. Med."},{"key":"1289_CR32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/molbev\/msu406","volume":"32","author":"LA Weinert","year":"2015","unstructured":"Weinert, L. A. et al. Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology. Mol. Biol. Evol. 32, 1020\u20131028 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"1289_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003368","volume":"9","author":"WJD Ouwendijk","year":"2013","unstructured":"Ouwendijk, W. J. D. et al. T-cell tropism of simian varicella virus during primary infection. PLoS Pathog. 9, e1003368 (2013).","journal-title":"PLoS Pathog."},{"key":"1289_CR34","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1073\/pnas.0501045102","volume":"102","author":"L Zerboni","year":"2005","unstructured":"Zerboni, L., Ku, C.-C., Jones, C. D., Zehnder, J. L. & Arvin, A. M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl Acad. Sci. USA 102, 6490\u20136495 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1289_CR35","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1128\/JVI.02396-10","volume":"85","author":"A Markus","year":"2011","unstructured":"Markus, A. et al. Varicella-zoster virus (VZV) infection of neurons derived from human embryonic stem cells: direct demonstration of axonal infection, transport of VZV, and productive neuronal infection. J. Virol. 85, 6220\u20136233 (2011).","journal-title":"J. Virol."},{"key":"1289_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13365-012-0124-z","volume":"18","author":"S Grigoryan","year":"2012","unstructured":"Grigoryan, S. et al. Retrograde axonal transport of VZV: kinetic studies in hESC-derived neurons. J. Neurovirol. 18, 462\u2013470 (2012).","journal-title":"J. Neurovirol."},{"key":"1289_CR37","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson, R. E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58, 9\u201320 (1965). This long-term population study demonstrated that herpes zoster incidence increases with age and is independent of epidemic spread, which led to the hypothesis that shingles results from an age-related loss of cell-mediated immunity that permits reactivation of latent VZV.","journal-title":"Proc. R. Soc. Med."},{"key":"1289_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy, I., Gershon, A. A., Steinberg, S. P. & LaRussa, P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N. Engl. J. Med. 325, 1545\u20131550 (1991).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJM199009063231002","volume":"323","author":"R Mahalingam","year":"1990","unstructured":"Mahalingam, R. et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N. Engl. J. Med. 323, 627\u2013631 (1990).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/306478a0","volume":"306","author":"DH Gilden","year":"1983","unstructured":"Gilden, D. H. et al. Varicella-zoster virus DNA in human sensory ganglia. Nature 306, 478\u2013480 (1983). This work provided direct molecular evidence that VZV establishes latency in human sensory ganglia.","journal-title":"Nature"},{"key":"1289_CR41","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1128\/jvi.69.12.8151-8154.1995","volume":"69","author":"P Clarke","year":"1995","unstructured":"Clarke, P., Beer, T., Cohrs, R. & Gilden, D. H. Configuration of latent varicella-zoster virus DNA. J. Virol. 69, 8151\u20138154 (1995).","journal-title":"J. Virol."},{"key":"1289_CR42","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1128\/JVI.80.10.4921-4926.2006","volume":"80","author":"L Gary","year":"2006","unstructured":"Gary, L., Gilden, D. H. & Cohrs, R. J. Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia. J. Virol. 80, 4921\u20134926 (2006).","journal-title":"J. Virol."},{"key":"1289_CR43","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1128\/JVI.01331-12","volume":"86","author":"WJD Ouwendijk","year":"2012","unstructured":"Ouwendijk, W. J. D. et al. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 86, 10203\u201310206 (2012).","journal-title":"J. Virol."},{"key":"1289_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20031-4","volume":"11","author":"WJD Ouwendijk","year":"2020","unstructured":"Ouwendijk, W. J. D. et al. Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency. Nat. Commun. 11, 6324 (2020). This study identified that alternative splicing produces transcripts that fuse VLT and ORF63 loci and showed that the resulting VLT-ORF63 fusion protein reinitiates VZV gene expression from latent viral genomes.","journal-title":"Nat. Commun."},{"key":"1289_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s13365-011-0070-1","volume":"17","author":"JJ Chen","year":"2011","unstructured":"Chen, J. J., Gershon, A. A., Li, Z., Cowles, R. A. & Gershon, M. D. Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J. Neurovirol. 17, 578\u2013589 (2011).","journal-title":"J. Neurovirol."},{"key":"1289_CR46","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/ije\/dyt213","volume":"42","author":"J-Y Chen","year":"2013","unstructured":"Chen, J.-Y. et al. Increased incidence of herpes zoster in adult patients with peptic ulcer disease: a population-based cohort study. Int. J. Epidemiol. 42, 1873\u20131881 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"1289_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","volume":"66","author":"G Smith","year":"2012","unstructured":"Smith, G. Herpesvirus transport to the nervous system and back again. Annu. Rev. Microbiol. 66, 153\u2013176 (2012).","journal-title":"Annu. Rev. Microbiol."},{"key":"1289_CR48","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.95.8.4658","volume":"95","author":"PGE Kennedy","year":"1998","unstructured":"Kennedy, P. G. E., Grinfeld, E. & Gow, J. W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl Acad. Sci. USA 95, 4658\u20134662 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1289_CR49","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/JVI.77.12.6979-6987.2003","volume":"77","author":"MJ Levin","year":"2003","unstructured":"Levin, M. J., Cai, G.-Y., Manchak, M. D. & Pizer, L. I. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol. 77, 6979\u20136987 (2003).","journal-title":"J. Virol."},{"key":"1289_CR50","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1128\/JVI.79.22.14079-14087.2005","volume":"79","author":"K Wang","year":"2005","unstructured":"Wang, K., Lau, T. Y., Morales, M., Mont, E. K. & Straus, S. E. Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J. Virol. 79, 14079\u201314087 (2005).","journal-title":"J. Virol."},{"key":"1289_CR51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm2500293","volume":"392","author":"J Guo","year":"2025","unstructured":"Guo, J. & Li, W. Ramsay Hunt syndrome. N. Engl. J. Med. 392, e53 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jvoice.2013.02.011","volume":"27","author":"L Nisa","year":"2013","unstructured":"Nisa, L., Landis, B. N., Giger, R. & Leuchter, I. Pharyngolaryngeal involvement by varicella-zoster virus. J. Voice 27, 636\u2013641 (2013).","journal-title":"J. Voice"},{"key":"1289_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/A:1011883919058","volume":"23","author":"DH Gilden","year":"2001","unstructured":"Gilden, D. H. et al. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 23, 145\u2013147 (2001).","journal-title":"Virus Genes"},{"key":"1289_CR54","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/13550280701447059","volume":"13","author":"K H\u00fcfner","year":"2007","unstructured":"H\u00fcfner, K. et al. The prevalence of human herpesvirus 6 in human sensory ganglia and its co-occurrence with alpha-herpesviruses. J. Neurovirol. 13, 462\u2013467 (2007).","journal-title":"J. Neurovirol."},{"key":"1289_CR55","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1128\/JVI.01070-14","volume":"88","author":"MA Nagel","year":"2014","unstructured":"Nagel, M. A. et al. Frequency and abundance of alphaherpesvirus DNA in human thoracic sympathetic ganglia. J. Virol. 88, 8189\u20138192 (2014).","journal-title":"J. Virol."},{"key":"1289_CR56","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1086\/648474","volume":"200","author":"ER Richter","year":"2009","unstructured":"Richter, E. R., Dias, J. K., Gilbert, J. E. II & Atherton, S. S. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J. Infect. Dis. 200, 1901\u20131906 (2009).","journal-title":"J. Infect. Dis."},{"key":"1289_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/v10040156","volume":"10","author":"WJD Ouwendijk","year":"2018","unstructured":"Ouwendijk, W. J. D., Veen, S., van, Mehraban, T., Mahalingam, R. & Verjans, G. M. G. M. Simian varicella virus infects enteric neurons and \u03b14\u03b27 integrin-expressing gut-tropic T-cells in nonhuman primates. Viruses 10, 156 (2018).","journal-title":"Viruses"},{"key":"1289_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ana.10662","volume":"54","author":"N Hemling","year":"2003","unstructured":"Hemling, N. et al. Herpesviruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann. Neurol. 54, 267\u2013271 (2003).","journal-title":"Ann. Neurol."},{"key":"1289_CR59","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/jnnp.62.6.586","volume":"62","author":"WR Lin","year":"1997","unstructured":"Lin, W. R., Casas, I., Wilcock, G. K. & Itzhaki, R. F. Neurotropic viruses and Alzheimer\u2019s disease: a search for varicella zoster virus DNA by the polymerase chain reaction. J. Neurol. Neurosurg. Psychiatry 62, 586\u2013589 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1289_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/jnnp.50.3.247","volume":"50","author":"GI Carter","year":"1987","unstructured":"Carter, G. I., Taylor, G. R. & Crow, T. J. Search for viral nucleic acid sequences in the post mortem brains of patients with schizophrenia and individuals who have committed suicide. J. Neurol. Neurosurg. Psychiatry 50, 247\u2013251 (1987).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1289_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jmv.20152","volume":"74","author":"D Theil","year":"2004","unstructured":"Theil, D. et al. Prevalence and distribution of HSV-1, VZV, and HHV-6 in human cranial nerve nuclei III, IV, VI, VII, and XII. J. Med. Virol. 74, 102\u2013106 (2004).","journal-title":"J. Med. Virol."},{"key":"1289_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jinf.2023.08.002","volume":"87","author":"J Penner","year":"2023","unstructured":"Penner, J. et al. Translating metagenomics into clinical practice for complex paediatric neurological presentations. J. Infect. 87, 451\u2013458 (2023).","journal-title":"J. Infect."},{"key":"1289_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004885","volume":"11","author":"A Markus","year":"2015","unstructured":"Markus, A., Lebenthal-Loinger, I., Yang, I. H., Kinchington, P. R. & Goldstein, R. S. An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons. PLoS Pathog. 11, e1004885 (2015).","journal-title":"PLoS Pathog."},{"key":"1289_CR64","doi-asserted-by":"publisher","first-page":"e00640","DOI":"10.1128\/JVI.00640-17","volume":"91","author":"S Kurapati","year":"2017","unstructured":"Kurapati, S. et al. Role of JNK pathway in varicella-zoster virus lytic infection and reactivation. J. Virol. 91, e00640\u201317 (2017).","journal-title":"J. Virol."},{"key":"1289_CR65","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1073\/pnas.1522575113","volume":"113","author":"T Sadaoka","year":"2016","unstructured":"Sadaoka, T. et al. In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency. Proc. Natl Acad. Sci. USA 113, E2403\u2013E2412 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1289_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012367","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Repression of varicella zoster virus gene expression during quiescent infection in the absence of detectable histone deposition. PLoS Pathog. 21, e1012367 (2025).","journal-title":"PLoS Pathog."},{"key":"1289_CR67","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/infdis\/jiy358","volume":"218","author":"DP Depledge","year":"2018","unstructured":"Depledge, D. P. et al. High viral diversity and mixed infections in cerebral spinal fluid from cases of varicella zoster virus encephalitis. J. Infect. Dis. 218, 1592\u20131601 (2018).","journal-title":"J. Infect. Dis."},{"key":"1289_CR68","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1086\/500835","volume":"193","author":"MA Quinlivan","year":"2006","unstructured":"Quinlivan, M. A. et al. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions. J. Infect. Dis. 193, 927\u2013930 (2006).","journal-title":"J. Infect. Dis."},{"key":"1289_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0022-510X(72)90120-7","volume":"15","author":"MM Esiri","year":"1972","unstructured":"Esiri, M. M., Tomlinson, A. H. & Herpes, Z. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J. Neurol. Sci. 15, 35\u201348 (1972).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR70","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1128\/JVI.03445-13","volume":"88","author":"M Steain","year":"2014","unstructured":"Steain, M. et al. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J. Virol. 88, 2704\u20132716 (2014).","journal-title":"J. Virol."},{"key":"1289_CR71","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/jmv.21173","volume":"80","author":"RJ Cohrs","year":"2008","unstructured":"Cohrs, R. J., Mehta, S. K., Schmid, D. S., Gilden, D. H. & Pierson, D. L. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J. Med. Virol. 80, 1116\u20131122 (2008).","journal-title":"J. Med. Virol."},{"key":"1289_CR72","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR73","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/165.4.619","volume":"165","author":"ME Devlin","year":"1992","unstructured":"Devlin, M. E., Gilden, D. H., Mahalingam, R., Dueland, A. N. & Cohrs, R. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J. Infect. Dis. 165, 619\u2013622 (1992).","journal-title":"J. Infect. Dis."},{"key":"1289_CR74","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1128\/JCM.00874-07","volume":"45","author":"M Quinlivan","year":"2007","unstructured":"Quinlivan, M. et al. Effect of viral load on the outcome of herpes zoster. J. Clin. Microbiol. 45, 3909\u20133914 (2007).","journal-title":"J. Clin. Microbiol."},{"key":"1289_CR75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/infdis\/jir425","volume":"204","author":"MA Nagel","year":"2011","unstructured":"Nagel, M. A. et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J. Infect. Dis. 204, 820\u2013824 (2011).","journal-title":"J. Infect. Dis."},{"key":"1289_CR76","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/v14071438","volume":"14","author":"M Mourad","year":"2022","unstructured":"Mourad, M. et al. Silent reactivation of varicella zoster virus in pregnancy: implications for maintenance of immunity to varicella. Viruses 14, 1438 (2022).","journal-title":"Viruses"},{"key":"1289_CR77","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/infdis\/153.5.840","volume":"153","author":"P Ljungman","year":"1986","unstructured":"Ljungman, P. et al. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J. Infect. Dis. 153, 840\u2013847 (1986).","journal-title":"J. Infect. Dis."},{"key":"1289_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/00006454-198205000-00007","volume":"1","author":"AA Gershon","year":"1982","unstructured":"Gershon, A. A., Steinberg, S. P., Borkowsky, W., Lennette, D. & Lennette, E. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster. Pediatr. Infect. Dis. J. 1, 164\u2013167 (1982).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1289_CR79","first-page":"243","volume":"342","author":"D Gilden","year":"2010","unstructured":"Gilden, D., Cohrs, R. J., Mahalingam, R. & Nagel, M. A. Neurological disease produced by varicella-zoster virus reactivation without rash. Curr. Top. Microbiol. Immunol. 342, 243\u2013253 (2010).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1289_CR80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1386-6532(02)00020-3","volume":"25","author":"M Koskiniemi","year":"2002","unstructured":"Koskiniemi, M. et al. Acute central nervous system complications in varicella zoster virus infections. J. Clin. Virol. 25, 293\u2013301 (2002).","journal-title":"J. Clin. Virol."},{"key":"1289_CR81","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.44.10.1818","volume":"44","author":"DH Gilden","year":"1994","unstructured":"Gilden, D. H. et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44, 1818\u20131823 (1994).","journal-title":"Neurology"},{"key":"1289_CR82","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1097\/INF.0000000000000418","volume":"33","author":"A Aslan","year":"2014","unstructured":"Aslan, A., Kurugol, Z. & Gokben, S. Acute transverse myelitis complicating breakthrough varicella infection. Pediatr. Infect. Dis. J. 33, 1196\u20131198 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1289_CR83","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1128\/jcm.29.7.1513-1516.1991","volume":"29","author":"E Puchhammer-St\u00f6ckl","year":"1991","unstructured":"Puchhammer-St\u00f6ckl, E., Popow-Kraupp, T., Heinz, F. X., Mandl, C. W. & Kunz, C. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J. Clin. Microbiol. 29, 1513\u20131516 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"1289_CR84","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archneur.1978.00500350073016","volume":"35","author":"ACB Peters","year":"1978","unstructured":"Peters, A. C. B., Versteeg, J., Lindeman, J. & Bots, G. T. A. M. Varicella and acute cerebellar ataxia. Arch. Neurol. 35, 769\u2013771 (1978).","journal-title":"Arch. Neurol."},{"key":"1289_CR85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2009.07.012","volume":"42","author":"AL Rack","year":"2010","unstructured":"Rack, A. L. et al. Neurologic varicella complications before routine immunization in Germany. Pediatr. Neurol. 42, 40\u201348 (2010).","journal-title":"Pediatr. Neurol."},{"key":"1289_CR86","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ane.12335","volume":"131","author":"L Pollak","year":"2015","unstructured":"Pollak, L. et al. Varicella-zoster DNA in saliva of patients with meningoencephalitis: a preliminary study. Acta Neurol. Scand. 131, 417\u2013421 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"1289_CR87","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/cid\/ciaa185","volume":"72","author":"LK Herlin","year":"2020","unstructured":"Herlin, L. K. et al. Varicella zoster virus encephalitis in Denmark from 2015 to 2019 \u2014 a nationwide prospective cohort study. Clin. Infect. Dis. 72, 1192\u20131199 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR88","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/brain\/114.3.1181","volume":"114","author":"O Devinsky","year":"1991","unstructured":"Devinsky, O., Cho, E.-S., Petito, C. K. & Price, R. W. Herpes zoster myelitis. Brain 114, 1181\u20131196 (1991).","journal-title":"Brain"},{"key":"1289_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/INF.0b013e318273e43d","volume":"32","author":"M Ibraheem","year":"2013","unstructured":"Ibraheem, M. et al. Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child. Pediatr. Infect. Dis. J. 32, 183\u2013185 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1289_CR90","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.STR.17.5.1024","volume":"17","author":"S Fukumoto","year":"2018","unstructured":"Fukumoto, S., Kinjo, M., Hokamura, K. & Tanaka, K. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions. Stroke 17, 1024\u20131028 (2018).","journal-title":"Stroke"},{"key":"1289_CR91","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archneur.1980.00500530077013","volume":"37","author":"CC Linnemann","year":"1980","unstructured":"Linnemann, C. C. & Alvira, M. M. Pathogenesis of varicella-zoster angiitis in the CNS. Arch. Neurol. 37, 239\u2013240 (1980).","journal-title":"Arch. Neurol."},{"key":"1289_CR92","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jns.2008.08.015","volume":"276","author":"K Heerlein","year":"2009","unstructured":"Heerlein, K. et al. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J. Neurol. Sci. 276, 184\u2013186 (2009).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jneuroim.2018.05.005","volume":"321","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients. J. Neuroimmunol. 321, 36\u201340 (2018).","journal-title":"J. Neuroimmunol."},{"key":"1289_CR94","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1017\/S0317167100001074","volume":"27","author":"C Adams","year":"2000","unstructured":"Adams, C., Diadori, P., Schoenroth, L. & Fritzler, M. Autoantibodies in childhood post-varicella acute cerebellar ataxia. Can. J. Neurol. Sci. 27, 316\u2013320 (2000).","journal-title":"Can. J. Neurol. Sci."},{"key":"1289_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jnnp.71.2.272","volume":"71","author":"P Defresne","year":"2001","unstructured":"Defresne, P. et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J. Neurol. Neurosurg. Psychiatry 71, 272\u2013274 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1289_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1038","volume":"11","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Cerebrospinal fluid proteomics in meningitis patients with reactivated varicella zoster virus. Immun. Inflamm. Dis. 11, e1038 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"1289_CR97","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1016\/j.ijid.2012.11.024","volume":"17","author":"E Gowin","year":"2013","unstructured":"Gowin, E., Wysocki, J. & Michalak, M. Don\u2019t forget how severe varicella can be \u2014 complications of varicella in children in a defined Polish population. Int. J. Infect. Dis. 17, e485\u2013e489 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"1289_CR98","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.vaccine.2018.04.012","volume":"36","author":"SE MacDonald","year":"2018","unstructured":"MacDonald, S. E. et al. Is varicella vaccination associated with pediatric arterial ischemic stroke? A population-based cohort study. Vaccine 36, 2764\u20132767 (2018).","journal-title":"Vaccine"},{"key":"1289_CR99","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2014.01.044","volume":"339","author":"MA Nagel","year":"2014","unstructured":"Nagel, M. A., Khmeleva, N., Choe, A., Gutierrez, J. & Gilden, D. Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation. J. Neurol. Sci. 339, 32\u201334 (2014).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR100","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/WNL.0b013e3182267bfa","volume":"77","author":"MA Nagel","year":"2011","unstructured":"Nagel, M. A. et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 77, 364\u2013370 (2011).","journal-title":"Neurology"},{"key":"1289_CR101","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.0b013e31827b1ab9","volume":"80","author":"MA Nagel","year":"2013","unstructured":"Nagel, M. A. et al. Varicella-zoster virus vasculopathy. Neurology 80, 62\u201368 (2013).","journal-title":"Neurology"},{"key":"1289_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-510X(03)00167-9","volume":"215","author":"PGE Kennedy","year":"2003","unstructured":"Kennedy, P. G. E., Grinfeld, E. & Esiri, M. M. Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J. Neurol. Sci. 215, 27\u201329 (2003).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR103","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yexmp.2015.12.007","volume":"100","author":"DJ Pisapia","year":"2016","unstructured":"Pisapia, D. J. & Lavi, E. VZV, temporal arteritis, and clinical practice: false positive immunohistochemical detection due to antibody cross-reactivity. Exp. Mol. Pathol. 100, 114\u2013115 (2016).","journal-title":"Exp. Mol. Pathol."},{"key":"1289_CR104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/infdis\/jiaa566","volume":"223","author":"RM Verdijk","year":"2020","unstructured":"Verdijk, R. M., Ouwendijk, W. J. D., Kuijpers, R. W. A. M. & Verjans, G. M. G. M. No evidence of varicella-zoster virus infection in temporal artery biopsies of anterior ischemic optic neuropathy patients with and without giant cell arteritis. J. Infect. Dis. 223, 109\u2013112 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR105","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/joa.13765","volume":"241","author":"L Terrier","year":"2022","unstructured":"Terrier, L., Bergemer, A., Destrieux, C. & Maldonado, I. L. Anatomical study of the carotid-trigeminal interface: the missing link in the trigeminovascular system? J. Anat. 241, 1303\u20131309 (2022).","journal-title":"J. Anat."},{"key":"1289_CR106","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden, D., Cohrs, R. J., Mahalingam, R. & Nagel, M. A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 8, 731\u2013740 (2009). This Review integrates clinical, pathological and virological data to describe how VZV infection leads to vasculopathies and discusses diagnostic and therapeutic options.","journal-title":"Lancet Neurol."},{"key":"1289_CR107","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cne.902230105","volume":"223","author":"MR Mayberg","year":"1984","unstructured":"Mayberg, M. R., Zervas, N. T. & Moskowitz, M. A. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J. Comp. Neurol. 223, 46\u201356 (1984).","journal-title":"J. Comp. Neurol."},{"key":"1289_CR108","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1523\/JNEUROSCI.06-08-02200.1986","volume":"6","author":"T O\u2019Connor","year":"1986","unstructured":"O\u2019Connor, T. & van der Kooy, D. Pattern of intracranial and extracranial projections of trigeminal ganglion cells. J. Neurosci. 6, 2200\u20132207 (1986).","journal-title":"J. Neurosci."},{"key":"1289_CR109","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","volume":"10","author":"VF Corrales-Medina","year":"2010","unstructured":"Corrales-Medina, V. F., Madjid, M. & Musher, D. M. Role of acute infection in triggering acute coronary syndromes. Lancet Infect. Dis. 10, 83\u201392 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"1289_CR110","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneurol.2009.271","volume":"67","author":"MSV Elkind","year":"2010","unstructured":"Elkind, M. S. V. et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch. Neurol. 67, 33\u201338 (2010).","journal-title":"Arch. Neurol."},{"key":"1289_CR111","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/infdis\/jiac405","volume":"227","author":"AN Bubak","year":"2022","unstructured":"Bubak, A. N. et al. Zoster-associated prothrombotic plasma exosomes and increased stroke risk. J. Infect. Dis. 227, 993\u20131001 (2022).","journal-title":"J. Infect. Dis."},{"key":"1289_CR112","doi-asserted-by":"publisher","first-page":"e00848","DOI":"10.1128\/jvi.00848-24","volume":"98","author":"CS Niemeyer","year":"2024","unstructured":"Niemeyer, C. S. et al. Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles. J. Virol. 98, e00848\u201324 (2024).","journal-title":"J. Virol."},{"key":"1289_CR113","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"1289_CR114","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99, 64\u201382.e7 (2018).","journal-title":"Neuron"},{"key":"1289_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79800-2","volume":"10","author":"M Eckerstr\u00f6m","year":"2020","unstructured":"Eckerstr\u00f6m, M., Nilsson, S., Zetterberg, H., Blennow, K. & Grahn, A. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study. Sci. Rep. 10, 22400 (2020).","journal-title":"Sci. Rep."},{"key":"1289_CR116","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/infdis\/jiaa513","volume":"223","author":"AN Bubak","year":"2020","unstructured":"Bubak, A. N. et al. Amylin, A\u03b242, and amyloid in varicella zoster virus vasculopathy cerebrospinal fluid and infected vascular cells. J. Infect. Dis. 223, 1284\u20131294 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR117","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-020-00227-w","volume":"10","author":"M Shinomoto","year":"2021","unstructured":"Shinomoto, M. et al. Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer\u2019s disease. Transl. Neurodegener. 10, 2 (2021).","journal-title":"Transl. Neurodegener."},{"key":"1289_CR118","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","volume":"221","author":"AN Bubak","year":"2020","unstructured":"Bubak, A. N. et al. Varicella-zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-\u03b2, and an amyloidogenic extracellular environment. J. Infect. Dis. 221, 1088\u20131097 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR119","doi-asserted-by":"publisher","first-page":"eaay8828","DOI":"10.1126\/sciadv.aay8828","volume":"6","author":"DM Cairns","year":"2020","unstructured":"Cairns, D. M. et al. A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease. Sci. Adv. 6, eaay8828 (2020).","journal-title":"Sci. Adv."},{"key":"1289_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13044","volume":"32","author":"DN Tran","year":"2022","unstructured":"Tran, D. N. et al. No evidence of aberrant amyloid \u03b2 and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain. Brain Pathol. 32, e13044 (2022).","journal-title":"Brain Pathol."},{"key":"1289_CR121","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086\u20131093.e2 (2023).","journal-title":"Neuron"},{"key":"1289_CR122","doi-asserted-by":"publisher","first-page":"117315","DOI":"10.1016\/j.jns.2021.117315","volume":"422","author":"T Mescher","year":"2021","unstructured":"Mescher, T., Boyer, P. J., Bubak, A. N., Hassell, J. E. & Nagel, M. A. Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy. J. Neurol. Sci. 422, 117315 (2021).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR123","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/pathogens2020364","volume":"2","author":"K Haberthur","year":"2013","unstructured":"Haberthur, K. & Messaoudi, I. Animal models of varicella zoster virus infection. Pathogens 2, 364\u2013382 (2013).","journal-title":"Pathogens"},{"key":"1289_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007617","volume":"15","author":"GD Chiara","year":"2019","unstructured":"Chiara, G. D. et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 15, e1007617 (2019).","journal-title":"PLoS Pathog."},{"key":"1289_CR125","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cmi.2024.12.025","volume":"31","author":"LS Duerlund","year":"2025","unstructured":"Duerlund, L. S., Nielsen, H. & Bodilsen, J. Current epidemiology of infectious encephalitis: a narrative review. Clin. Microbiol. Infect. 31, 515\u2013521 (2025).","journal-title":"Clin. Microbiol. Infect."},{"key":"1289_CR126","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/brain\/awad089","volume":"146","author":"PT Petersen","year":"2023","unstructured":"Petersen, P. T. et al. Clinical features and prognostic factors in adults with viral meningitis. Brain 146, 3816\u20133825 (2023).","journal-title":"Brain"},{"key":"1289_CR127","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/bjd.19687","volume":"184","author":"HJ Forbes","year":"2021","unstructured":"Forbes, H. J. et al. Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data. Br. J. Dermatol. 184, 1077\u20131084 (2021).","journal-title":"Br. J. Dermatol."},{"key":"1289_CR128","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jiz652","volume":"222","author":"HF Tseng","year":"2020","unstructured":"Tseng, H. F. et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults \u226550 years old: incidence, complications, hospitalization, mortality, and recurrence. J. Infect. Dis. 222, 798\u2013806 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR129","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","volume":"75","author":"C Schr\u00f6der","year":"2017","unstructured":"Schr\u00f6der, C., Enders, D., Schink, T. & Riedel, O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J. Infect. 75, 207\u2013215 (2017).","journal-title":"J. Infect."},{"key":"1289_CR130","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s40121-024-01002-4","volume":"13","author":"N Giannelos","year":"2024","unstructured":"Giannelos, N. et al. The incidence of herpes zoster complications: a systematic literature review. Infect. Dis. Ther. 13, 1461\u20131486 (2024).","journal-title":"Infect. Dis. Ther."},{"key":"1289_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2556","volume":"34","author":"M Heiat","year":"2024","unstructured":"Heiat, M. et al. A comprehensive, updated systematic review and meta-analysis of epidemiologic evidence on the connection between herpes zoster infection and the risk of stroke. Rev. Med. Virol. 34, e2556 (2024).","journal-title":"Rev. Med. Virol."},{"key":"1289_CR132","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13365-023-01144-0","volume":"29","author":"P Lu","year":"2023","unstructured":"Lu, P., Cui, L. & Zhang, X. Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis. J. Neurovirol. 29, 449\u2013459 (2023).","journal-title":"J. Neurovirol."},{"key":"1289_CR133","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/acn3.51525","volume":"9","author":"C Warren-Gash","year":"2022","unstructured":"Warren-Gash, C. et al. No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann. Clin. Transl. Neurol. 9, 363\u2013374 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1289_CR134","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/ene.14795","volume":"28","author":"C Schnier","year":"2021","unstructured":"Schnier, C. et al. Antiherpetic medication and incident dementia: observational cohort studies in four countries. Eur. J. Neurol. 28, 1840\u20131848 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1289_CR135","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1212\/WNL.0000000000200709","volume":"99","author":"SAJ Schmidt","year":"2022","unstructured":"Schmidt, S. A. J., Veres, K., S\u00f8rensen, H. T., Obel, N. & Henderson, V. W. Incident herpes zoster and risk of dementia: a population-based Danish cohort study. Neurology 99, e660\u2013e668 (2022).","journal-title":"Neurology"},{"key":"1289_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296957","volume":"19","author":"S Weinmann","year":"2024","unstructured":"Weinmann, S. et al. Herpes zoster diagnosis and treatment in relation to incident dementia: a population-based retrospective matched cohort study. PLoS ONE 19, e0296957 (2024).","journal-title":"PLoS ONE"},{"key":"1289_CR137","doi-asserted-by":"publisher","first-page":"153331752110065","DOI":"10.1177\/15333175211006504","volume":"36","author":"HG Choi","year":"2021","unstructured":"Choi, H. G. et al. Herpes zoster does not increase the risk of neurodegenerative dementia: a case-control study. Am. J. Alzheimer\u2019s Dis. Other Dement. 36, 15333175211006504 (2021).","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"1289_CR138","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045871","volume":"11","author":"A Lophatananon","year":"2021","unstructured":"Lophatananon, A. et al. Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study \u2014 results from the UK Biobank cohort. BMJ Open. 11, e045871 (2021).","journal-title":"BMJ Open."},{"key":"1289_CR139","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13195-021-00905-5","volume":"13","author":"S-Y Huang","year":"2021","unstructured":"Huang, S.-Y. et al. Herpesvirus infections and Alzheimer\u2019s disease: a Mendelian randomization study. Alzheimer\u2019s Res. Ther. 13, 158 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"1289_CR140","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00406-020-01157-4","volume":"271","author":"S Bae","year":"2021","unstructured":"Bae, S. et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur. Arch. Psychiatry Clin. Neurosci. 271, 987\u2013997 (2021).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1289_CR141","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031116","volume":"101","author":"Y Shim","year":"2022","unstructured":"Shim, Y., Park, M. & Kim, J. Increased incidence of dementia following herpesvirus infection in the Korean population. Medicine 101, e31116 (2022).","journal-title":"Medicine"},{"key":"1289_CR142","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-024-01418-7","volume":"16","author":"E Shin","year":"2024","unstructured":"Shin, E. et al. The associations of herpes simplex virus and varicella zoster virus infection with dementia: a nationwide retrospective cohort study. Alzheimer\u2019s Res. Ther. 16, 57 (2024).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"1289_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188490","volume":"12","author":"M-C Tsai","year":"2017","unstructured":"Tsai, M.-C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE 12, e0188490 (2017).","journal-title":"PLoS ONE"},{"key":"1289_CR144","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/infdis\/jiab013","volume":"224","author":"LH Omland","year":"2021","unstructured":"Omland, L. H. et al. Characteristics and long-term prognosis of Danish patients with varicella zoster virus detected in cerebrospinal fluid compared with the background population. J. Infect. Dis. 224, 850\u2013859 (2021).","journal-title":"J. Infect. Dis."},{"key":"1289_CR145","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.tjpad.2025.100167","volume":"12","author":"L Blandi","year":"2025","unstructured":"Blandi, L. et al. Herpes zoster as risk factor for dementia: a matched cohort study over 20 years in a 10-million population in Italy. J. Prev. Alzheimer\u2019s Dis. 12, 100167 (2025).","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"1289_CR146","doi-asserted-by":"publisher","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","volume":"79","author":"VC-H Chen","year":"2018","unstructured":"Chen, V. C.-H. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry 79, 16m11312 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"1289_CR147","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4065\/mcp.2010.0618","volume":"86","author":"BP Yawn","year":"2011","unstructured":"Yawn, B. P., Wollan, P. C., Kurland, M. J., Sauver, J. L. S. & Saddier, P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin. Proc. 86, 88\u201393 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"1289_CR148","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10072-023-07038-7","volume":"45","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. The association between varicella zoster virus and dementia: a systematic review and meta-analysis of observational studies. Neurol. Sci. 45, 27\u201336 (2024).","journal-title":"Neurol. Sci."},{"key":"1289_CR149","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034503","volume":"102","author":"RH Elhalag","year":"2023","unstructured":"Elhalag, R. H. et al. Herpes zoster virus infection and the risk of developing dementia: a systematic review and meta-analysis. Medicine 102, e34503 (2023).","journal-title":"Medicine"},{"key":"1289_CR150","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00415-016-8316-8","volume":"264","author":"J Granerod","year":"2017","unstructured":"Granerod, J. et al. Increased rates of sequelae post-encephalitis in individuals attending primary care practices in the United Kingdom: a population-based retrospective cohort study. J. Neurol. 264, 407\u2013415 (2017).","journal-title":"J. Neurol."},{"key":"1289_CR151","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","volume":"18","author":"ST Pendlebury","year":"2019","unstructured":"Pendlebury, S. T. & Rothwell, P. M. & Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 18, 248\u2013258 (2019).","journal-title":"Lancet Neurol."},{"key":"1289_CR152","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipil\u00e4","year":"2021","unstructured":"Sipil\u00e4, P. N. et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect. Dis. 21, 1557\u20131567 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1289_CR153","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s43587-024-00621-3","volume":"4","author":"LS Richmond-Rakerd","year":"2024","unstructured":"Richmond-Rakerd, L. S. et al. Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis. Nat. Aging 4, 783\u2013790 (2024).","journal-title":"Nat. Aging"},{"key":"1289_CR154","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M. N. et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352, 2271\u20132284 (2005).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR155","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/eurheartj\/ehaf230","volume":"46","author":"S Lee","year":"2025","unstructured":"Lee, S. et al. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur. Heart J. 46, 2991\u20133002 (2025).","journal-title":"Eur. Heart J."},{"key":"1289_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12293","volume":"8","author":"C Schnier","year":"2022","unstructured":"Schnier, C., Janbek, J., Lathe, R. & Haas, J. Reduced dementia incidence after varicella zoster vaccination in Wales 2013\u20132020. Alzheimer\u2019s Dement. 8, e12293 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1289_CR157","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JAD-221231","volume":"95","author":"K Harris","year":"2023","unstructured":"Harris, K. et al. The impact of routine vaccinations on Alzheimer\u2019s disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching. J. Alzheimer\u2019s Dis. 95, 703\u2013718 (2023).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1289_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16768-4","volume":"23","author":"A Lophatananon","year":"2023","unstructured":"Lophatananon, A. et al. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink. BMC Public Health 23, 1903 (2023).","journal-title":"BMC Public Health"},{"key":"1289_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257405","volume":"16","author":"JF Scherrer","year":"2021","unstructured":"Scherrer, J. F. et al. Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts. PLoS ONE 16, e0257405 (2021).","journal-title":"PLoS ONE"},{"key":"1289_CR160","doi-asserted-by":"publisher","first-page":"126673","DOI":"10.1016\/j.vaccine.2024.126673","volume":"46","author":"E Tang","year":"2025","unstructured":"Tang, E., Ray, I., Arnold, B. F. & Acharya, N. R. Recombinant zoster vaccine and the risk of dementia. Vaccine 46, 126673 (2025).","journal-title":"Vaccine"},{"key":"1289_CR161","doi-asserted-by":"publisher","first-page":"112411","DOI":"10.1016\/j.exger.2024.112411","volume":"190","author":"S Ukraintseva","year":"2024","unstructured":"Ukraintseva, S. et al. Associations of infections and vaccines with Alzheimer\u2019s disease point to a role of compromised immunity rather than specific pathogen in AD. Exp. Gerontol. 190, 112411 (2024).","journal-title":"Exp. Gerontol."},{"key":"1289_CR162","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/jgs.17606","volume":"70","author":"TL Wiemken","year":"2022","unstructured":"Wiemken, T. L. et al. Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations. J. Am. Geriatr. Soc. 70, 1157\u20131168 (2022).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1289_CR163","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/jech-2021-217090","volume":"76","author":"T Wilkinson","year":"2022","unstructured":"Wilkinson, T. et al. Drug prescriptions and dementia incidence: a medication-wide association study of 17000 dementia cases among half a million participants. J. Epidemiol. Community Health 76, 223\u2013229 (2022).","journal-title":"J. Epidemiol. Community Health"},{"key":"1289_CR164","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","volume":"7","author":"L Simonsen","year":"2007","unstructured":"Simonsen, L., Taylor, R. J., Viboud, C., Miller, M. A. & Jackson, L. A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 7, 658\u2013666 (2007).","journal-title":"Lancet Infect. Dis."},{"key":"1289_CR165","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1001\/jama.2025.5013","volume":"333","author":"M Pomirchy","year":"2025","unstructured":"Pomirchy, M. et al. Herpes zoster vaccination and dementia occurrence. JAMA 333, 2083\u20132092 (2025).","journal-title":"JAMA"},{"key":"1289_CR166","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0549-y","volume":"14","author":"K Walters","year":"2016","unstructured":"Walters, K. et al. Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med. 14, 6 (2016).","journal-title":"BMC Med."},{"key":"1289_CR167","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14336","volume":"6","author":"MS Weinberg","year":"2023","unstructured":"Weinberg, M. S. et al. Association of BCG vaccine treatment with death and dementia in patients with non\u2013muscle-invasive bladder cancer. JAMA Netw. Open 6, e2314336 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1289_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01172-3","volume":"10","author":"M Taquet","year":"2025","unstructured":"Taquet, M., Todd, J. A. & Harrison, P. J. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. npj Vaccines 10, 130 (2025).","journal-title":"npj Vaccines"},{"key":"1289_CR169","doi-asserted-by":"publisher","first-page":"127413","DOI":"10.1016\/j.vaccine.2025.127413","volume":"61","author":"D Carter","year":"2025","unstructured":"Carter, D. et al. The success of toll-like receptor 4 based vaccine adjuvants. Vaccine 61, 127413 (2025).","journal-title":"Vaccine"},{"key":"1289_CR170","doi-asserted-by":"publisher","first-page":"115938","DOI":"10.1016\/j.celrep.2025.115938","volume":"44","author":"JR Fergusson","year":"2025","unstructured":"Fergusson, J. R. et al. Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant. Cell Rep. 44, 115938 (2025).","journal-title":"Cell Rep."},{"key":"1289_CR171","doi-asserted-by":"publisher","first-page":"2465909","DOI":"10.1080\/10717544.2025.2465909","volume":"32","author":"M Rafiei","year":"2025","unstructured":"Rafiei, M., Shojaei, A. & Chau, Y. Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia. Drug Deliv. 32, 2465909 (2025).","journal-title":"Drug Deliv."},{"key":"1289_CR172","doi-asserted-by":"publisher","first-page":"eadl3381","DOI":"10.1126\/scitranslmed.adl3381","volume":"16","author":"V Bechtold","year":"2024","unstructured":"Bechtold, V. et al. Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine. Sci. Transl. Med. 16, eadl3381 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1289_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013759","volume":"21","author":"MJ Johnson","year":"2025","unstructured":"Johnson, M. J. et al. The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGF\u03b2. PLoS Pathog. 21, e1013759 (2025).","journal-title":"PLoS Pathog."},{"key":"1289_CR174","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell 188, 2992\u20133012.e16 (2025).","journal-title":"Cell"},{"key":"1289_CR175","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-025-09662-z","volume":"648","author":"P Ayata","year":"2025","unstructured":"Ayata, P. et al. Lymphoid gene expression supports neuroprotective microglia function. Nature 648, 157\u2013165 (2025).","journal-title":"Nature"},{"key":"1289_CR176","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1007\/s11064-023-03974-0","volume":"48","author":"M Zheng","year":"2023","unstructured":"Zheng, M. et al. Intranasal monophosphoryl lipid A administration ameliorates depression-like behavior in chronically stressed mice through stimulation of microglia. Neurochem. Res. 48, 3160\u20133176 (2023).","journal-title":"Neurochem. Res."},{"key":"1289_CR177","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1093\/brain\/awac316","volume":"145","author":"RF Buckley","year":"2022","unstructured":"Buckley, R. F. Sex differences in Alzheimer\u2019s disease risk: are immune responses the key? Brain 145, 3341\u20133342 (2022).","journal-title":"Brain"},{"key":"1289_CR178","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41577-024-00996-9","volume":"24","author":"KS Forsyth","year":"2024","unstructured":"Forsyth, K. S., Jiwrajka, N., Lovell, C. D., Toothacre, N. E. & Anguera, M. C. The conneXion between sex and immune responses. Nat. Rev. Immunol. 24, 487\u2013502 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1289_CR179","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/vaccines12050527","volume":"12","author":"L Losa","year":"2024","unstructured":"Losa, L. et al. Immunogenicity of recombinant zoster vaccine: a systematic review, meta-analysis, and meta-regression. Vaccines 12, 527 (2024).","journal-title":"Vaccines"},{"key":"1289_CR180","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/vaccines13040340","volume":"13","author":"A Weinberg","year":"2025","unstructured":"Weinberg, A., Vu, T., Johnson, M. J., Schmid, D. S. & Levin, M. J. The reduced immunogenicity of zoster vaccines in CMV-seropositive older adults correlates with T cell imprinting. Vaccines 13, 340 (2025).","journal-title":"Vaccines"},{"key":"1289_CR181","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/infdis\/jiy383","volume":"218","author":"A Weinberg","year":"2018","unstructured":"Weinberg, A. et al. Comparative immune responses to licensed herpes zoster vaccines. J. Infect. Dis. 218, S81\u2013S87 (2018).","journal-title":"J. Infect. Dis."},{"key":"1289_CR182","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molmed.2018.07.009","volume":"24","author":"ME Carter-Timofte","year":"2018","unstructured":"Carter-Timofte, M. E., Paludan, S. R. & Mogensen, T. H. RNA polymerase III as a gatekeeper to prevent severe VZV infections. Trends Mol. Med. 24, 904\u2013915 (2018). This Review provides a comprehensive description of Pol III biology and discusses the role of this cytosolic DNA sensor in antiviral immunity to VZV.","journal-title":"Trends Mol. Med."},{"key":"1289_CR183","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.cmi.2022.02.023","volume":"28","author":"TH Mogensen","year":"2022","unstructured":"Mogensen, T. H. Genetic susceptibility to viral disease in humans. Clin. Microbiol. Infect. 28, 1411\u20131416 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1289_CR184","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212427","volume":"219","author":"CJA Duncan","year":"2022","unstructured":"Duncan, C. J. A. et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J. Exp. Med. 219, e20212427 (2022).","journal-title":"J. Exp. Med."},{"key":"1289_CR185","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220028","volume":"219","author":"P Bastard","year":"2022","unstructured":"Bastard, P. et al. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes. J. Exp. Med. 219, e20220028 (2022).","journal-title":"J. Exp. Med."},{"key":"1289_CR186","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220491","volume":"219","author":"I Meyts","year":"2022","unstructured":"Meyts, I. Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic. J. Exp. Med. 219, e20220491 (2022).","journal-title":"J. Exp. Med."},{"key":"1289_CR187","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1172\/JCI92280","volume":"127","author":"B Ogunjimi","year":"2017","unstructured":"Ogunjimi, B. et al. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Invest. 127, 3543\u20133556 (2017). This study identified POLR3A and POLR3C gene defects in children with VZV encephalitis and showed that defective Pol III-mediated cytosolic DNA sensing underpins impaired antiviral immunity.","journal-title":"J. Clin. Invest."},{"key":"1289_CR188","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","volume":"138","author":"Y-H Chiu","year":"2009","unstructured":"Chiu, Y.-H., MacMillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576\u2013591 (2009).","journal-title":"Cell"},{"key":"1289_CR189","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ni.1779","volume":"10","author":"A Ablasser","year":"2009","unstructured":"Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065\u20131072 (2009).","journal-title":"Nat. Immunol."},{"key":"1289_CR190","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41435-018-0027-y","volume":"20","author":"ME Carter-Timofte","year":"2019","unstructured":"Carter-Timofte, M. E., Hansen, A. F., Christiansen, M., Paludan, S. R. & Mogensen, T. H. Mutations in RNA polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection. Genes Immun. 20, 214\u2013223 (2019).","journal-title":"Genes Immun."},{"key":"1289_CR191","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/infdis\/jiab254","volume":"224","author":"MM Thomsen","year":"2021","unstructured":"Thomsen, M. M. et al. Genetic variants and immune responses in a cohort of patients with varicella zoster virus encephalitis. J. Infect. Dis. 224, 2122\u20132132 (2021).","journal-title":"J. Infect. Dis."},{"key":"1289_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29690","volume":"96","author":"JL Heinz","year":"2024","unstructured":"Heinz, J. L. et al. Varicella zoster virus-induced autophagy in human neuronal and hematopoietic cells exerts antiviral activity. J. Med. Virol. 96, e29690 (2024).","journal-title":"J. Med. Virol."},{"key":"1289_CR193","first-page":"1295","volume":"221","author":"F Liang","year":"2020","unstructured":"Liang, F. et al. Recurrent herpes zoster ophthalmicus in a patient with a novel Toll-like receptor 3 variant linked to compromised activation capacity in fibroblasts. J. Infect. Dis. 221, 1295\u20131303 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR194","doi-asserted-by":"publisher","first-page":"1177245","DOI":"10.3389\/fimmu.2023.1177245","volume":"14","author":"EV Breedam","year":"2023","unstructured":"Breedam, E. V. et al. Lack of strong innate immune reactivity renders macrophages alone unable to control productive varicella-zoster virus infection in an isogenic human iPSC-derived neuronal co-culture model. Front. Immunol. 14, 1177245 (2023).","journal-title":"Front. Immunol."},{"key":"1289_CR195","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3390\/v14112517","volume":"14","author":"M Boeren","year":"2022","unstructured":"Boeren, M. et al. Activation of interferon-stimulated genes following varicella-zoster virus infection in a human iPSC-derived neuronal in vitro model depends on exogenous interferon-\u03b1. Viruses 14, 2517 (2022).","journal-title":"Viruses"},{"key":"1289_CR196","doi-asserted-by":"publisher","first-page":"1458967","DOI":"10.3389\/fimmu.2024.1458967","volume":"15","author":"J Govaerts","year":"2024","unstructured":"Govaerts, J. et al. Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids. Front. Immunol. 15, 1458967 (2024).","journal-title":"Front. Immunol."},{"key":"1289_CR197","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41577-020-0391-5","volume":"21","author":"SR Paludan","year":"2021","unstructured":"Paludan, S. R., Pradeu, T., Masters, S. L. & Mogensen, T. H. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137\u2013150 (2021). This Review proposes an early antiviral component of the innate immune system that is constitutively present and serves to eliminate viral infection and dampen cell stress independently of classic type I interferon immunity while maintaining cellular homeostasis.","journal-title":"Nat. Rev. Immunol."},{"key":"1289_CR198","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/v13061053","volume":"13","author":"J Heinz","year":"2021","unstructured":"Heinz, J., Kennedy, P. G. E. & Mogensen, T. H. The role of autophagy in varicella zoster virus infection. Viruses 13, 1053 (2021).","journal-title":"Viruses"},{"key":"1289_CR199","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/cid\/ciu1161","volume":"60","author":"S Grabar","year":"2015","unstructured":"Grabar, S. et al. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. Clin. Infect. Dis. 60, 1269\u20131277 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR200","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2008.07.019","volume":"275","author":"Y Miyazaki","year":"2008","unstructured":"Miyazaki, Y. et al. VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male. J. Neurol. Sci. 275, 42\u201345 (2008).","journal-title":"J. Neurol. Sci."},{"key":"1289_CR201","first-page":"1","volume":"438","author":"DP Depledge","year":"2021","unstructured":"Depledge, D. P. & Breuer, J. Varicella-zoster virus, genetics, pathogenesis and immunity. Curr. Top. Microbiol. Immunol. 438, 1\u201323 (2021).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1289_CR202","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1128\/JVI.00407-13","volume":"87","author":"TL Rovi\u0161","year":"2013","unstructured":"Rovi\u0161, T. L. et al. Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection. J. Virol. 87, 6943\u20136954 (2013).","journal-title":"J. Virol."},{"key":"1289_CR203","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/infdis\/157.5.882","volume":"157","author":"L Dubey","year":"1988","unstructured":"Dubey, L., Steinberg, S. P., LaRussa, P., Oh, P. & Gershon, A. A. Western blot analysis of antibody to varicella-zoster virus. J. Infect. Dis. 157, 882\u2013888 (1988).","journal-title":"J. Infect. Dis."},{"key":"1289_CR204","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1128\/JVI.05194-11","volume":"86","author":"M Kalantari-Dehaghi","year":"2012","unstructured":"Kalantari-Dehaghi, M. et al. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J. Virol. 86, 4328\u20134339 (2012).","journal-title":"J. Virol."},{"key":"1289_CR205","doi-asserted-by":"publisher","first-page":"103747","DOI":"10.1016\/j.ebiom.2021.103747","volume":"75","author":"DR Monaco","year":"2022","unstructured":"Monaco, D. R. et al. Deconvoluting virome-wide antibody epitope reactivity profiles. EBioMedicine 75, 103747 (2022).","journal-title":"EBioMedicine"},{"key":"1289_CR206","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/infdis\/168.5.1256","volume":"168","author":"M Ito","year":"1993","unstructured":"Ito, M. et al. Inhibition of varicella-zoster virus (VZV) glycoprotein expression by a human monoclonal antibody against VZV glycoprotein III. J. Infect. Dis. 168, 1256\u20131259 (1993).","journal-title":"J. Infect. Dis."},{"key":"1289_CR207","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/eji.1830170309","volume":"17","author":"T Sugano","year":"1987","unstructured":"Sugano, T., Matsumoto, Y., Miyamoto, C. & Masuho, Y. Hybridomas producing human monoclonal antibodies against varicella-zoster virus. Eur. J. Immunol. 17, 359\u2013364 (1987).","journal-title":"Eur. J. Immunol."},{"key":"1289_CR208","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1099\/0022-1317-72-9-2065","volume":"72","author":"T Sugano","year":"1991","unstructured":"Sugano, T. et al. A human monoclonal antibody against varicella-zoster virus glycoprotein III. J. Gen. Virol. 72, 2065\u20132073 (1991).","journal-title":"J. Gen. Virol."},{"key":"1289_CR209","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jmv.20838","volume":"79","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K., Akahori, Y., Asano, Y., Kurosawa, Y. & Shiraki, K. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity. J. Med. Virol. 79, 852\u2013862 (2007).","journal-title":"J. Med. Virol."},{"key":"1289_CR210","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1099\/vir.0.80406-0","volume":"85","author":"L Kausmally","year":"2004","unstructured":"Kausmally, L. et al. Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library. J. Gen. Virol. 85, 3493\u20133500 (2004).","journal-title":"J. Gen. Virol."},{"key":"1289_CR211","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1128\/JVI.02561-12","volume":"87","author":"M Birlea","year":"2012","unstructured":"Birlea, M. et al. Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH\/gL complex and neutralizes VZV infection. J. Virol. 87, 415\u2013421 (2012).","journal-title":"J. Virol."},{"key":"1289_CR212","doi-asserted-by":"publisher","first-page":"e00269","DOI":"10.1128\/JVI.00269-18","volume":"92","author":"NL Sullivan","year":"2018","unstructured":"Sullivan, N. L. et al. Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans. J. Virol. 92, e00269\u201318 (2018).","journal-title":"J. Virol."},{"key":"1289_CR213","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1128\/JVI.01020-10","volume":"84","author":"K Gowrishankar","year":"2010","unstructured":"Gowrishankar, K. et al. Characterization of the host immune response in human ganglia after herpes zoster. J. Virol. 84, 8861\u20138870 (2010).","journal-title":"J. Virol."},{"key":"1289_CR214","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jid.2021.06.038","volume":"142","author":"IU Egbuniwe","year":"2022","unstructured":"Egbuniwe, I. U. et al. B lymphocytes accumulate and proliferate in human skin at sites of cutaneous antigen challenge. J. Investig. Dermatol. 142, 726\u2013731.e4 (2022).","journal-title":"J. Investig. Dermatol."},{"key":"1289_CR215","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/01.pas.0000176427.99004.d7","volume":"30","author":"B Leinweber","year":"2006","unstructured":"Leinweber, B., Kerl, H. & Cerroni, L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella\/zoster). Am. J. Surg. Pathol. 30, 50\u201358 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"1289_CR216","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/microorganisms11020519","volume":"11","author":"D Pan","year":"2023","unstructured":"Pan, D., Wang, W. & Cheng, T. Current methods for the detection of antibodies of varicella-zoster virus: a review. Microorganisms 11, 519 (2023).","journal-title":"Microorganisms"},{"key":"1289_CR217","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1073\/pnas.0610847104","volume":"104","author":"GMGM Verjans","year":"2007","unstructured":"Verjans, G. M. G. M. et al. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl Acad. Sci. USA 104, 3496\u20133501 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1289_CR218","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003547","volume":"9","author":"Mvan Velzen","year":"2013","unstructured":"Velzen, M. van et al. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog. 9, e1003547 (2013).","journal-title":"PLoS Pathog."},{"key":"1289_CR219","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.4049\/jimmunol.1502366","volume":"196","author":"L Jing","year":"2016","unstructured":"Jing, L. et al. Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses. J. Immunol. 196, 2205\u20132218 (2016).","journal-title":"J. Immunol."},{"key":"1289_CR220","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.4049\/jimmunol.1302307","volume":"192","author":"WJD Ouwendijk","year":"2014","unstructured":"Ouwendijk, W. J. D. et al. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells. J. Immunol. 192, 3730\u20133739 (2014).","journal-title":"J. Immunol."},{"key":"1289_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004008","volume":"10","author":"C Chiu","year":"2014","unstructured":"Chiu, C. et al. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog. 10, e1004008 (2014).","journal-title":"PLoS Pathog."},{"key":"1289_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02820-y","volume":"20","author":"Mvan Gent","year":"2023","unstructured":"Gent, M. van et al. Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia. J. Neuroinflammation 20, 141 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1289_CR223","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/cid\/ciy984","volume":"69","author":"NL Sullivan","year":"2019","unstructured":"Sullivan, N. L. et al. Characterization of virus-specific immune response during varicella zoster virus encephalitis in a young adult. Clin. Infect. Dis. 69, 348\u2013351 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34698-4","volume":"13","author":"KJ Laing","year":"2022","unstructured":"Laing, K. J. et al. Selective retention of virus-specific tissue-resident T cells in healed skin after recovery from herpes zoster. Nat. Commun. 13, 6957 (2022).","journal-title":"Nat. Commun."},{"key":"1289_CR225","doi-asserted-by":"publisher","first-page":"114062","DOI":"10.1016\/j.celrep.2024.114062","volume":"43","author":"M Boeren","year":"2024","unstructured":"Boeren, M. et al. Lack of functional TCR\u2013epitope interaction is associated with herpes zoster through reduced downstream T cell activation. Cell Rep. 43, 114062 (2024).","journal-title":"Cell Rep."},{"key":"1289_CR226","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/605611","volume":"200","author":"A Weinberg","year":"2009","unstructured":"Weinberg, A. et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J. Infect. Dis. 200, 1068\u20131077 (2009).","journal-title":"J. Infect. Dis."},{"key":"1289_CR227","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","volume":"132","author":"SR Bialek","year":"2013","unstructured":"Bialek, S. R. et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics 132, e1134\u2013e1140 (2013).","journal-title":"Pediatrics"},{"key":"1289_CR228","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","volume":"210","author":"PB Gilbert","year":"2014","unstructured":"Gilbert, P. B. et al. Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve. J. Infect. Dis. 210, 1573\u20131581 (2014).","journal-title":"J. Infect. Dis."},{"key":"1289_CR229","doi-asserted-by":"publisher","first-page":"2445384","DOI":"10.1080\/21645515.2024.2445384","volume":"21","author":"AL Cunningham","year":"2025","unstructured":"Cunningham, A. L., Sandgren, K. J. & Taylor, J. Current status of immunisation for herpes zoster. Hum. Vaccines Immunother. 21, 2445384 (2025).","journal-title":"Hum. Vaccines Immunother."},{"key":"1289_CR230","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/infdis\/jiaa300","volume":"224","author":"A Hastie","year":"2020","unstructured":"Hastie, A. et al. Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination. J. Infect. Dis. 224, 2025\u20132034 (2020).","journal-title":"J. Infect. Dis."},{"key":"1289_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57562-7","volume":"16","author":"X Wen","year":"2025","unstructured":"Wen, X. et al. Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine. Nat. Commun. 16, 2332 (2025).","journal-title":"Nat. Commun."},{"key":"1289_CR232","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","volume":"16","author":"P Wutzler","year":"2017","unstructured":"Wutzler, P. et al. Varicella vaccination \u2014 the global experience. Expert Rev. Vaccines 16, 833\u2013843 (2017).","journal-title":"Expert Rev. Vaccines"},{"key":"1289_CR233","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/14760584.2017.1294069","volume":"16","author":"J Leung","year":"2017","unstructured":"Leung, J., Broder, K. R. & Marin, M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert. Rev. Vaccines 16, 391\u2013400 (2017).","journal-title":"Expert. Rev. Vaccines"},{"key":"1289_CR234","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa064040","volume":"356","author":"SS Chaves","year":"2007","unstructured":"Chaves, S. S. et al. Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med. 356, 1121\u20131129 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR235","doi-asserted-by":"publisher","first-page":"e02381","DOI":"10.1128\/jcm.02381-21","volume":"60","author":"P Bryant","year":"2022","unstructured":"Bryant, P. et al. Vaccine strain and wild-type clades of varicella-zoster virus in central nervous system and non-CNS disease, New York State, 2004\u20132019. J. Clin. Microbiol. 60, e02381\u201321 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"1289_CR236","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/infdis\/jiq066","volume":"203","author":"BA Pahud","year":"2011","unstructured":"Pahud, B. A., Glaser, C. A., Dekker, C. L., Arvin, A. M. & Schmid, D. S. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J. Infect. Dis. 203, 316\u2013323 (2011).","journal-title":"J. Infect. Dis."},{"key":"1289_CR237","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/molbev\/mst210","volume":"31","author":"DP Depledge","year":"2014","unstructured":"Depledge, D. P. et al. Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol. Biol. Evol. 31, 397\u2013409 (2014).","journal-title":"Mol. Biol. Evol."},{"key":"1289_CR238","first-page":"17","volume":"123","author":"AA Gershon","year":"2012","unstructured":"Gershon, A. A. et al. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans. Am. Clin. Climatol. Assoc. 123, 17\u201333 (2012).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"1289_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08809-5","volume":"23","author":"C Miller","year":"2023","unstructured":"Miller, C. et al. Progressive shingles in a toddler due to reactivation of varicella zoster vaccine virus four days after infection with SARS-CoV-2; a case report. BMC Infect. Dis. 23, 854 (2023).","journal-title":"BMC Infect. Dis."},{"key":"1289_CR240","doi-asserted-by":"publisher","first-page":"S387","DOI":"10.1093\/infdis\/jiaa573","volume":"224","author":"AA Gershon","year":"2021","unstructured":"Gershon, A. A., Gershon, M. D. & Shapiro, E. D. Live attenuated varicella vaccine: prevention of varicella and of zoster. J. Infect. Dis. 224, S387\u2013S397 (2021).","journal-title":"J. Infect. Dis."},{"key":"1289_CR241","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2917","volume":"144","author":"S Weinmann","year":"2019","unstructured":"Weinmann, S. et al. Incidence of herpes zoster among children: 2003\u20132014. Pediatrics 144, e20182917 (2019).","journal-title":"Pediatrics"},{"key":"1289_CR242","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann, S. et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009. J. Infect. Dis. 208, 1859\u20131868 (2013).","journal-title":"J. Infect. Dis."},{"key":"1289_CR243","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","volume":"28","author":"R Civen","year":"2009","unstructured":"Civen, R. et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatric Infect. Dis. J. 28, 954\u2013959 (2009).","journal-title":"Pediatric Infect. Dis. J."},{"key":"1289_CR244","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066485","volume":"8","author":"B Ogunjimi","year":"2013","unstructured":"Ogunjimi, B., Damme, P. V. & Beutels, P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS ONE 8, e66485 (2013).","journal-title":"PLoS ONE"},{"key":"1289_CR245","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1016\/j.vaccine.2014.10.015","volume":"32","author":"J Luyten","year":"2014","unstructured":"Luyten, J., Ogunjimi, B. & Beutels, P. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. Vaccine 32, 7175\u20137178 (2014).","journal-title":"Vaccine"},{"key":"1289_CR246","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s40588-016-0044-4","volume":"3","author":"SL Oliver","year":"2016","unstructured":"Oliver, S. L., Yang, E. & Arvin, A. M. Varicella-zoster virus glycoproteins: entry, replication, and pathogenesis. Curr. Clin. Microbiol. Rep. 3, 204\u2013215 (2016).","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"1289_CR247","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11427-015-4887-3","volume":"58","author":"W Wang","year":"2015","unstructured":"Wang, W., Cheng, T., Zhu, H. & Xia, N. Insights into the function of tegument proteins from the varicella zoster virus. Sci. China Life Sci. 58, 739\u2013749 (2015).","journal-title":"Sci. China Life Sci."},{"key":"1289_CR248","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1099\/0022-1317-67-9-1759","volume":"67","author":"AJ Davison","year":"1986","unstructured":"Davison, A. J. & Scott, J. E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67, 1759\u20131816 (1986).","journal-title":"J. Gen. Virol."},{"key":"1289_CR249","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2004.11.007","volume":"119","author":"JJ Chen","year":"2004","unstructured":"Chen, J. J., Zhu, Z., Gershon, A. A. & Gershon, M. D. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 119, 915\u2013926 (2004).","journal-title":"Cell"},{"key":"1289_CR250","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01227-21","volume":"95","author":"L Rajbhandari","year":"2021","unstructured":"Rajbhandari, L. et al. Nectin-1 is an entry mediator for varicella-zoster virus infection of human neurons. J. Virol. 95, e0122721 (2021).","journal-title":"J. Virol."},{"key":"1289_CR251","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1073\/pnas.0913351107","volume":"107","author":"T Suenaga","year":"2010","unstructured":"Suenaga, T. et al. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl Acad. Sci. USA 107, 866\u2013871 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1289_CR252","doi-asserted-by":"publisher","first-page":"6372","DOI":"10.1128\/jvi.68.10.6372-6390.1994","volume":"68","author":"AA Gershon","year":"1994","unstructured":"Gershon, A. A. et al. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J. Virol. 68, 6372\u20136390 (1994).","journal-title":"J. Virol."},{"key":"1289_CR253","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1007\/s00018-004-4269-7","volume":"61","author":"S Hambleton","year":"2004","unstructured":"Hambleton, S., Gershon, M. D. & Gershon, A. A. The role of the trans-Golgi network in varicella zoster virus biology. Cell. Mol. Life Sci. 61, 3047\u20133056 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"1289_CR254","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1128\/jvi.69.8.4994-5010.1995","volume":"69","author":"R Harson","year":"1995","unstructured":"Harson, R. & Grose, C. Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J. Virol. 69, 4994\u20135010 (1995).","journal-title":"J. Virol."},{"key":"1289_CR255","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07479-z","volume":"22","author":"SL Cadogan","year":"2022","unstructured":"Cadogan, S. L., Mindell, J. S., Breuer, J., Hayward, A. & Warren-Gash, C. Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England. BMC Infect. Dis. 22, 513 (2022).","journal-title":"BMC Infect. Dis."},{"key":"1289_CR256","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","volume":"4","author":"SL Thomas","year":"2004","unstructured":"Thomas, S. L. & Hall, A. J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 4, 26\u201333 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"1289_CR257","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jinf.2014.08.016","volume":"70","author":"B Ogunjimi","year":"2014","unstructured":"Ogunjimi, B. et al. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. J. Infect. 70, 171\u2013177 (2014).","journal-title":"J. Infect."},{"key":"1289_CR258","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden, D. H., Kleinschmidt-DeMasters, B. K., LaGuardia, J. J., Mahalingam, R. & Cohrs, R. J. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342, 635\u2013645 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1289_CR259","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin, R. H. et al. Recommendations for the management of herpes zoster. Clin. Infect. Dis. 44, S1\u2013S26 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"1289_CR260","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1212\/WNL.51.5.1405","volume":"51","author":"M Haanp\u00e4\u00e4","year":"1998","unstructured":"Haanp\u00e4\u00e4, M. et al. CSF and MRI findings in patients with acute herpes zoster. Neurology 51, 1405\u20131411 (1998).","journal-title":"Neurology"},{"key":"1289_CR261","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/01455613221077594","volume":"103","author":"CF Roy","year":"2024","unstructured":"Roy, C. F., Turkdogan, S., Silver, J. A. & Young, J. Herpes zoster of the larynx: a narrow diagnostic and therapeutic window. Ear Nose Throat J. 103, 611\u2013613 (2024).","journal-title":"Ear Nose Throat J."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01289-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:03:17Z","timestamp":1779192197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01289-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":261,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01289-9","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}